DSIP (Delta Sleep-Inducing Peptide)

What Is DSIP? The Nonapeptide Named for an EEG Effect

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

DSIP is a nine-residue peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, isolated from rabbit cerebral venous blood in 1977 and named for delta-wave EEG activity observed after administration. Despite the name, no DSIP gene, precursor protein or receptor has been characterised in the decades since.

Key facts

Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Single-letter
WAGGDASGE
Length
9 residues (nonapeptide)
Molecular weight
848.8 Da
Molecular formula
C35H48N10O15
CAS number
62568-57-4
PubChem CID
68816
INN
Emideltide
Gene / receptor
Neither identified

Where it came from

Schoenenberger, Monnier and colleagues in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, and isolated a small peptide from it. Administered into the cerebral ventricles of awake rabbits, the fraction was reported to produce the slow delta-wave EEG pattern characteristic of deep sleep. The isolation was published in the Proceedings of the National Academy of Sciences in March 1977; the sequence followed in Pflügers Archiv in 1978.

The name is a hypothesis, not a finding

Delta sleep-inducing peptide describes what the discoverers believed they had found. That is normal for the era and not a criticism of the original work. It becomes a problem when the name is treated as a summary of established pharmacology, because the evidence behind it has never firmed up. A compound whose name asserts an effect will be read as having that effect, and readers rarely check whether the name was ever earned.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

What was never established

This is the central fact about DSIP and it is routinely omitted. No DSIP gene has been isolated. No precursor protein has been identified. No receptor has been characterised. For a peptide proposed as an endogenous signalling molecule, that combination is remarkable. The usual route from isolation to accepted biology runs through exactly those three things, and DSIP has completed none of them in nearly fifty years.

How the field describes it

Kovalzon's 2006 review in the Journal of Neurochemistry is titled 'Delta sleep-inducing peptide (DSIP): a still unresolved riddle'. That is a fair summary of the literature's own assessment: a peptide with a substantial body of published work (roughly 519 indexed records) that has neither been confirmed as a sleep factor nor definitively dismissed.

A species detail

The peptide was isolated from rabbit. The relationship between the rabbit sequence and any human counterpart is part of what remains unresolved, and it matters because a peptide's endogenous role in one species does not establish one in another. Without an identified gene in any species, even this question stays open.

Regulatory position

DSIP holds no marketing authorisation from the MHRA, EMA or FDA. It carries an International Nonproprietary Name, emideltide, which reflects that a name was assigned rather than that a product was approved. It is supplied for laboratory research only.

Frequently asked questions

Does DSIP induce sleep?

The 1977 work reported delta-wave EEG activity in rabbits after administration. That an effect was observed in that experiment is not the same as the effect being established, and the subsequent literature has not resolved it.

Is DSIP a natural human peptide?

It was isolated from rabbit blood. No DSIP gene has been identified in any species, so its status as an endogenous peptide remains unconfirmed.

What is emideltide?

The International Nonproprietary Name assigned to DSIP. An INN is a naming decision, not an approval.

Is DSIP approved anywhere?

No. It holds no marketing authorisation and is supplied for laboratory research only.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.